Delivery of MenACWY vaccines to 19-25 year-old students in London during September 2017

Tender description

London Region is looking for any existing qualified providers to deliver MenACWY vaccine to 19-25 year old students during September 2017. London's community pharmacies are exempt from this procurement process since they will apply and be processed via SONAR platform as a Contract Variation to their Core Contract. MenACWY vaccine was introduced in 2015 to respond to a rapid and accelerating increase in cases of invasive meningococcal group W (MenW) disease, which had been declared a national incident. The MenACWY conjugate vaccine provides direct protection to the vaccinated cohort and, by reducing MenW carriage, will also provide indirect protection to unvaccinated children and adults. This follows advice from the Joint Committee on Vaccination and Immunisation (JCVI). This commission is for September - October 2017 only. This contract period is an estimation as there is a stock of 15,000 additional vaccines ordered for this purpose and this AQP service will run until this central stock of vaccines has been exhausted. Any Qualified Provider seeking authorisation to proceed should register an interest in this opportunity via the ProContract portal, complete the online questionnaire and submit this completed questionnaire before the stated submission deadline of 17.00 on Friday 1 September 2017. Activity will be reimbursed at the standard London region price of £9.80 per vaccination for MenACWY 19-25. No further payment is provided as part of this service delivery. This procurement is being conducted as an AQP process for a short-term time limited contract under the NHS Standard Contract 2017/18 terms and conditions. The services to which this procurement relate fall under Schedule 3 of the Public Contracts Regulations (PCR) 2015 and, as such, NHS England do not intend to hold themselves bound to any of the PCR regulations save those applicable to services procured under the "Light Touch Regime".